← All trials
NCT04381871
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Aug 1, 2020
- Completion date
- Sep 1, 2020
- First posted
- May 11, 2020
- Last posted
- May 12, 2020
- Enrollment
- 110
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Al-Neelain UniversityLead sponsor
- University of KhartoumCollaborator
- Al-Neelain UniversityReponsible party - principal investigator
- Al-Neelain UniversityStudy chair
- University of KhartoumStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.